Comparison of Image-Guided Iodine-125 Seed Interstitial Brachytherapy and Local Chemotherapy Perfusion in Treatment of Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Image-Guided Iodine-125 Seed Interstitial Brachytherapy and Local Chemotherapy Perfusion in Treatment of Advanced Pancreatic Cancer

Published:2020-08-30 Issue:1 Volume:35 Page:1-6
ISSN:0894-1939
Container-title:Journal of Investigative Surgery
language:en
Short-container-title:Journal of Investigative Surgery

Author:

Zhou Li¹,Yang Hui¹,Xie Linjun²,Sun Jiantong²,Qian Jun¹,Zhu Lifei³

Affiliation:

1. Department of Oncology, Suzhou Hospital of Nanjing Medical University, Suzhou, China

2. Department of Pharmacy, Suzhou Hospital of Nanjing Medical University, Suzhou, China

3. Department of Pathology, Suzhou Hospital of Nanjing Medical University, Suzhou, China

Publisher

Informa UK Limited

Subject

Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/08941939.2020.1805057

Reference20 articles.

1. Board PATE. Pancreatic Cancer Treatment (PDQ®). 2018.

2. Adjuvant Chemotherapy in Pancreatic Cancer

3. Pancreatic cancer

4. Pancreatic cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop report;Journal of Cancer Research and Therapeutics;2024-08

2. Optimal strategies for the decumulation of retirement savings under differing appetites for liquidity and investment risks;Decisions in Economics and Finance;2024-05-25

3. Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov;Radiation Oncology;2024-02-13

4. Feasibility of 125I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer;Medicine;2023-11-03

5. Circulating Tumor Cells as a Risk Factor for Non-Small Cell Lung Cancer Treated with EGFR-TKI;INT J PHARMACOL;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3